<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/24264?offset=1340</link>
	<atom:link href="https://bioinformaticsonline.com/related/24264?offset=1340" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/8480/paper-test-for-cancer</guid>
	<pubDate>Wed, 26 Feb 2014 00:20:30 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/8480/paper-test-for-cancer</link>
	<title><![CDATA[Paper test for cancer !!!]]></title>
	<description><![CDATA[<p>The American Cancer Society projects the numbers of new cancer cases and deaths expected each year in order to estimate the contemporary cancer burden, because cancer incidence and mortality data lag three to four years behind the current year. In addition, the regularly updated Facts &amp; Figures publications present the most current trends in cancer occurrence and survival, as well as information on symptoms, prevention, early detection, and treatment. Cancer rates in developing nations have climbed sharply in recent years, and now account for 70 percent of cancer mortality worldwide. Early detection has been proven to improve outcomes, but screening approaches such as mammograms and colonoscopy, used in the developed world, are too costly to be implemented in settings with little medical infrastructure.</p><p>The US born Sangeeta Bhatia at Massachusetts Institute of Technology (MIT) has developed a cheap, simple, paper test that can detect cancer. These diagnostic, which works much like a pregnancy test, could reveal within minutes, based on a urine sample, whether a person have cancer or not. The MIT media announce the major and amazing breakthrough in cancer diagonistics. These newly developed technology will allow non-communicable diseases to be detect at early stage, which will be cheap and easily accessible to the masses. For the developing world it would be exciting to adapt it instead to a paper test that could be performed on unprocessed samples in a rural setting, without the need for any specialized equipment. The simple readout could even be transmitted to a remote caregiver by a picture on a mobile phone.</p><p>The MIT professor and Howard Hughes Medical Institute investigator Sangeeta Bhatia, who is also the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, invented a new class of synthetic biomarker, which is highly specialized instrument to do these kind of analysis. These paper test essentially relies on nanoparticles that interact with tumor proteins called proteases, each of which can trigger release of hundreds of biomarkers that are then easily detectable in a patient's urine. The MIT nanoparticles are coated with peptides (short protein fragments) targeted by different MMPs. These particles congregate at tumor sites, where MMPs cleave hundreds of peptides, which accumulate in the kidneys and are excreted in the urine.</p><p><img src="http://www.jasongrowclients.com/bhatia/source/image/100601e_bhatia_8122.jpg" width="400" height="600" alt="image" style="border: 0px;"><br /><br />To create the test strips, the researchers first coated nitrocellulose paper with antibodies that can capture the peptides. Once the peptides are captured, they flow along the strip and are exposed to several invisible test lines made of other antibodies specific to different tags attached to the peptides. If one of these lines becomes visible, it means the target peptide is present in the sample. The technology can also easily be modified to detect multiple types of peptides released by different types or stages of disease.<br /><br />In tests in mice, the researchers were able to accurately identify colon tumors, as well as blood clots. Bhatia says these tests represent the first step toward a diagnostic device that could someday be useful in human patients. "This is a new idea &mdash; to create an excreted biomarker instead of relying on what the body gives you," she says. "To prove this approach is really going to be a useful diagnostic, the next step is to test it in patient populations."</p><p>&nbsp;</p><p>Reference:</p><p>Image: jasongrowclients</p><p>Homepage: http://lmrt.mit.edu/about.html</p><p>http://web.mit.edu/newsoffice/2014/a-paper-diagnostic-for-cancer-0224.html</p><p>http://timesofindia.indiatimes.com/home/science/PIO-develops-cheap-paper-test-to-detect-cancer/articleshow/30963615.cms</p>]]></description>
	<dc:creator>Shruti Paniwala</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/12943/a-history-of-bioinformatics-in-the-year-2039</guid>
	<pubDate>Wed, 23 Jul 2014 06:37:51 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/12943/a-history-of-bioinformatics-in-the-year-2039</link>
	<title><![CDATA[A History of Bioinformatics (in the Year 2039)]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/uwsjwMO-TEA" frameborder="0" allowfullscreen></iframe><p>C. Titus Brown http://video.open-bio.org/video/1/a-history-of-bioinformatics-in-the-year-2039</p>]]></description>
	
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/41020/cancer-dependency-map</guid>
	<pubDate>Thu, 13 Feb 2020 04:38:47 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/41020/cancer-dependency-map</link>
	<title><![CDATA[Cancer Dependency Map]]></title>
	<description><![CDATA[<p><span>The consequences of alterations in the DNA of cancer cells and subsequent vulnerabilities are not fully understood. This project aims to assign a dependency to every cancer cell in a patient which could be exploited to develop new therapies. This knowledge is foundational for precision cancer medicine.</span></p><p>Address of the bookmark: <a href="https://depmap.sanger.ac.uk/" rel="nofollow">https://depmap.sanger.ac.uk/</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</guid>
	<pubDate>Tue, 05 Aug 2014 13:55:32 -0500</pubDate>
	<link>https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</link>
	<title><![CDATA[Genomics and sequencing approach for identification of biomarkers to assess the efficacy of TGF-βRI inhibitors (of liver cancer) in vivo]]></title>
	<description><![CDATA[<p>Liver cancer is third leading cause of deaths and fourth most frequent occuring cancer worldwide. There are multiple signaling pathways responsible for causing cancer amongst which TGFb is most important cytokine whose signaling pathway promote cancer. However, main problem is to cure this cancer at late stage where we still have no treatment strategy to tackle this deadly cancer. &nbsp;Hence we need to find out new therapeutic target. One way is to look the relationships between mRNA, methylation and miRNA data of patients with different pathological conditions (cancer vs control either with inhibitor/not). MiRNA is small RNA molecules known to inhibit mRNA expression of particular gene by binding improperly to 3'UTR region of a gene and hence block binding of TF /translation of gene. CpG regions is known to located at promoter region of gene (5' UTR) and usually hypomethylated which allow to gene to transcribe and translate however sometime this region become hyper-methylated thats prevent expression of host gene. Thus , integration of these three data reveal new targets and pathways important for causing or preventing cancer and also reveal biomarker thats check the effects of inhibitor on signaling pathway underlying liver cancer.</p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
	<enclosure url="https://bioinformaticsonline.com/file/download/13415" length="26423" type="image/jpeg" />
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/38383/sidow-lab</guid>
  <pubDate>Fri, 07 Dec 2018 09:06:30 -0600</pubDate>
  <link></link>
  <title><![CDATA[Sidow Lab]]></title>
  <description><![CDATA[
<p>We study mechanisms of cancer evolution by using state-of-the-art genomic approaches at the bench and in analysis. Accurate genome reconstruction is our other major area of interest. We also collaborate on important questions for which our expertise in genomics and computation is relevant. Arend's biosketch highlights some of our past contributions.</p>

<p>http://www.sidowlab.org/</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/2422/bioinformatics-codes-search</guid>
	<pubDate>Thu, 15 Aug 2013 11:08:52 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/2422/bioinformatics-codes-search</link>
	<title><![CDATA[Bioinformatics Codes Search]]></title>
	<description><![CDATA[<p>I bet, this website will be your best friend in near future. This helps us to explore the existing open source codes and learn from it.</p>
<p>You can find some useful open source bioinformatics codes for your analysis work. You can use the left bar options to filtere out or narrow down your search result. This webpage can be an useful resource for a beginners bioinformatician as it contain several bioinformatics basics script that are commonly used by biological programmers and biologist.</p>
<p>Stand on the slumped, dandruff-covered shoulders of millions of computer nerds. _/\_</p>
<p>Enjoy the code and research work.</p>
<p>http://code.ohloh.net/search?s=bioinformatics</p><p>Address of the bookmark: <a href="http://code.ohloh.net/search?s=bioinformatics" rel="nofollow">http://code.ohloh.net/search?s=bioinformatics</a></p>]]></description>
	<dc:creator>Jitendra Narayan</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/5191/programming-language-to-build-synthetic-dna</guid>
	<pubDate>Mon, 30 Sep 2013 16:37:24 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/5191/programming-language-to-build-synthetic-dna</link>
	<title><![CDATA[Programming language to build synthetic DNA]]></title>
	<description><![CDATA[<p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;">A team led by <a href="http://homes.cs.washington.edu/~seelig/index.html">Georg Seelig</a>&nbsp;(<a href="http://homes.cs.washington.edu/~seelig/index.html">http://homes.cs.washington.edu/~seelig/index.html</a>) at&nbsp;University of Washington has developed a programming language for chemistry that it hopes will streamline efforts to design a network that can guide the behavior of chemical-reaction mixtures in the same way that embedded electronic controllers guide cars, robots and other devices. In medicine, such networks could serve as &ldquo;smart&rdquo; drug deliverers or disease detectors at the cellular level.</p><p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;">Reference &amp; More @</p><p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;"><a href="http://www.nature.com/nnano/journal/vaop/ncurrent/full/nnano.2013.189.html">http://www.nature.com/nnano/journal/vaop/ncurrent/full/nnano.2013.189.html</a></p><p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;"><a href="http://www.washington.edu/news/2013/09/30/uw-engineers-invent-programming-language-to-build-synthetic-dna/">http://www.washington.edu/news/2013/09/30/uw-engineers-invent-programming-language-to-build-synthetic-dna/</a></p><p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;">Image source:&nbsp;washington.edu</p><p style="color: #333333; font-size: 13px; font-style: normal; font-weight: normal; text-align: start;"><img src="http://www.washington.edu/news/files/2013/09/Programmable-chemistry-2.jpg" alt="image" style="border: 0px; border: 0px;"></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/22938/research-assistant-in-computational-biology</guid>
  <pubDate>Wed, 24 Jun 2015 07:55:16 -0500</pubDate>
  <link></link>
  <title><![CDATA[Research assistant in computational biology]]></title>
  <description><![CDATA[
<p>http://www.au.dk/en/about/vacant-positions/scientific-positions/stillinger/Vacancy/show/743161/5283/</p>

<p>Qualifications:<br />MSc degree in computer science, engineering, genetics or similar field with a strong emphasis on computational methods.</p>

<p>Deadline<br />01.08.2015</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/38556/reactome-pathway-database</guid>
	<pubDate>Mon, 31 Dec 2018 02:41:33 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/38556/reactome-pathway-database</link>
	<title><![CDATA[Reactome Pathway Database]]></title>
	<description><![CDATA[<p><span>REACTOME is an open-source, open access, manually curated and peer-reviewed pathway database. Our goal is to provide intuitive bioinformatics tools for the visualization, interpretation and analysis of pathway knowledge to support basic and clinical research, genome analysis, modeling, systems biology and education. Founded in 2003, the Reactome project is led by Lincoln Stein of&nbsp;</span><a href="http://oicr.on.ca/">OICR</a><span>, Peter D&rsquo;Eustachio of&nbsp;</span><a href="http://nyulangone.org/">NYULMC</a><span>, Henning Hermjakob of&nbsp;</span><a href="http://www.ebi.ac.uk/">EMBL-EBI</a><span>, and Guanming Wu of&nbsp;</span><a href="http://www.ohsu.edu/">OHSU</a><span>.</span></p><p>Address of the bookmark: <a href="https://reactome.org/" rel="nofollow">https://reactome.org/</a></p>]]></description>
	<dc:creator>BioStar</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/44640/new-blast-core-nucleotide-database-core-nt</guid>
	<pubDate>Tue, 13 Aug 2024 07:12:53 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/44640/new-blast-core-nucleotide-database-core-nt</link>
	<title><![CDATA[New BLAST Core Nucleotide Database (core_nt)]]></title>
	<description><![CDATA[<p><span>The Core Nucleotide Database (core_nt) is now the default nucleotide BLAST database. Core_nt is also available on the command line. You get faster searches &amp; more focused results.</span></p><p><span><span>Core_nt contains the same eukaryotic transcript and gene-related sequences as nt. The core_nt database is nt without most eukaryotic chromosome sequences. Most nucleotide BLAST searches with core_nt will be similar to the nt database. However, core_nt is better than nt for accomplishing your most common BLAST search goals, such as identifying gene-related sequences like transcript sequences and complete bacterial chromosomes. This is because, in recent years, nt has acquired more low-relevance, non-annotated, and non-gene&nbsp;<span>content.&nbsp;</span></span></span></p><p><span> Learn more:&nbsp;https://ncbiinsights.ncbi.nlm.nih.gov/2024/07/18/new-blast-core-nucleotide-database/</span></p>]]></description>
	<dc:creator>LEGE</dc:creator>
</item>

</channel>
</rss>